[go: up one dir, main page]

CN1424041A - Kakonein preparations and their production - Google Patents

Kakonein preparations and their production Download PDF

Info

Publication number
CN1424041A
CN1424041A CN 02155198 CN02155198A CN1424041A CN 1424041 A CN1424041 A CN 1424041A CN 02155198 CN02155198 CN 02155198 CN 02155198 A CN02155198 A CN 02155198A CN 1424041 A CN1424041 A CN 1424041A
Authority
CN
China
Prior art keywords
puerarin
poloxamer
polyethylene glycol
stir
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02155198
Other languages
Chinese (zh)
Inventor
苏娟
张卫东
吴伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN 02155198 priority Critical patent/CN1424041A/en
Publication of CN1424041A publication Critical patent/CN1424041A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

本发明是一种葛根素滴丸制剂及其制备方法。该滴丸制剂以葛根素为主要成份,与聚乙二醇、泊洛沙姆按一定工艺组配制成。本发明的滴丸制剂与其余剂相比,药物起效快、生物利用度高,制备工艺适合于工业化生产。The invention relates to a puerarin dripping pill preparation and a preparation method thereof. The dropping pill preparation takes puerarin as the main component, and is prepared according to a certain process group with polyethylene glycol and poloxamer. Compared with other preparations, the dropping pill preparation of the present invention has quick drug onset and high bioavailability, and the preparation process is suitable for industrialized production.

Description

Puerarin dropping pill formulation and preparation method thereof
Technical field
The invention belongs to medical technical field, being specifically related to a kind of is oral solid formulation of main component and preparation method thereof with puerarin (Puerarin), is a kind of puerarin dropping pill formulation and preparation method thereof specifically.
Background technology
Puerarin has pharmacological action comparatively widely; experimental results show that puerarin has dilating effect to coronary artery; can protect global ischemia cardiac muscle and myocardial ischemia reperfusion injury; reduce the acute myocardial infarction area; reduce myocardial oxygen consumption; prevent platelet adhesion, gathering and thrombosis, puerarin has significant protective effect to acute cerebral ischemia, and B-adrenergic receptor is had blocking effect.Clinically, puerarin is mainly used in the treatment of diseases such as coronary heart disease, angina pectoris, myocardial infarction, ischemic cerebrovascular, sudden deafness, retina artery and vein obstruction.
At present the preparation of puerarin is in the majority with injection clinically, for example puerarin glucose injection, puerarin sodium chloride injection etc., and injection exists the shortcoming of patient's medication inconvenience when curative effect can be affirmed.At present the solid preparation of puerarin has only tablet, because the dissolubility of puerarin is bad, and the performance that tablet exists as problems affect curative effects such as absorbing slowly, bioavailability is little, and coronary heart disease, angina pectoris belong to clinical acute disease, rapid onset needs first aid.
Summary of the invention
The object of the present invention is to provide a kind of drug effect is fast, bioavailability is high oral puerarin dropping pill formulation and preparation method.
The puerarin dropping pill formulation that the present invention proposes, be a kind of oral solid formulation, it is Main Ingredients and Appearance with the puerarin, with Polyethylene Glycol (requiring its molecular weight greater than 1500) and poloxamer is that the compatibility component is formulated, the weight proportion of each component is: 1 part of puerarin, Polyethylene Glycol 2.5-6.5 part, poloxamer 0.5-2.0 part.
The puerarin dropping pill formulation that the present invention proposes, its preferred component weight proportion is: 1 part of puerarin, Polyethylene Glycol 3-5 part, poloxamer 0.5-1 part.
The primary structure formula of Main Ingredients and Appearance puerarin of the present invention is a following formula I:
Figure A0215519800041
Formula I
The preparation method of the puerarin dropping pill formulation that the present invention proposes is as follows: by the weight proportion of each component Polyethylene Glycol, poloxamer are placed in the water-bath and heat, make it fusion; Add puerarin, stir, add anhydrous alcohol for medical use, stir hydrotropy; Continue to stir volatilization ethanol, 85~100 ℃ of heat preservation for standby use; Preheating DW-1 type drop pill machine, making fluid storage compartment constant temperature is fluid temperature, the coolant soybean oil is chilled to 10~12 ℃ in advance, drips system with 28~32 droplets/minute the speed of dripping; Collect drop pill at valve port, the filtering coolant, and absorb surperficial oil stain, and dry, promptly get the molding drop pill.
The puerarin dropping pill formulation that the present invention makes has the advantage that drug effect is fast, bioavailability is high, and its process conditions advanced person, is fit to the characteristics of industrial-scale production.The tablet of puerarin is just stripping 18% in 45 minutes in 0.3% sodium dodecyl sulfate solution, and the stripping in 15 minutes under identical leaching condition of puerarin drop pill is complete, can guarantee that thus the onset of puerarin drop pill is faster than tablet.
The specific embodiment
Further specifically describe the present invention below by embodiment.
Embodiment 1:
The weight proportion of puerarin drop pill each component is:
Puerarin 6.25g
Polyethylene Glycol (6000) 25.66g
Poloxamer (188) 5.50g
The method for preparing the puerarin drop pill is as follows:
Polyethylene glycol 6000 25.66g, poloxamer 1885.50g are placed in the water-bath and heat, make it fusion; Add the 6.25g puerarin, stir, add anhydrous alcohol for medical use 3.67ml, stir hydrotropy, continue to stir, volatilization ethanol, 95 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 95 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 30 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Embodiment 2:
The weight proportion of puerarin drop pill each component is:
Puerarin 8.05g
Polyethylene Glycol (4000) 20.13g
Poloxamer (188) 16.10g
The method for preparing the puerarin drop pill is as follows:
Polyethylene Glycol (4000) 20.13g, poloxamer (188) 16.10g are placed in the water-bath and heat, make fusion; Add the 8.05g puerarin, stir, add anhydrous alcohol for medical use 4.57ml, stir hydrotropy, continue to stir, volatilization ethanol, 88 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 90 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 28 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Embodiment 3:
The weight proportion of puerarin drop pill each component is:
Puerarin 4.35g
Polyethylene Glycol (1500) 26.10g
Poloxamer (188) 6.53g
The method for preparing the puerarin drop pill is as follows:
Polyethylene Glycol (1500) 26.10g, poloxamer (188) 6.53g are placed in the water-bath and heat, make fusion; Add the 4.35g puerarin, stir, add anhydrous alcohol for medical use 5.32ml, stir hydrotropy, continue to stir, volatilization ethanol, 98 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 98 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 32 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Embodiment 4:
The weight proportion of puerarin drop pill each component is:
Puerarin 6.40g
Polyethylene Glycol (6000) 25.60g
Poloxamer (188) 12.8g
The method for preparing the puerarin drop pill is as follows:
Polyethylene Glycol (6000) 6.40g, poloxamer (188) 12.8g are placed in the water-bath and heat, make fusion; Add the 6.40g puerarin, stir, add anhydrous alcohol for medical use 7.08ml, stir hydrotropy, continue to stir, volatilization ethanol, 95 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 95 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 30 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.

Claims (3)

1、一种葛根素滴丸制剂,其特征在于以葛根素为主要成份,以分子量大于1500的聚乙二醇、泊洛沙姆为配伍组份配制而成,各组份的重量配比为:葛根素1份,聚乙二醇2.5~6.5份,泊洛沙姆0.5~2.0份。1. A puerarin dripping pill preparation is characterized in that taking puerarin as the main component, and polyethylene glycol and poloxamer with a molecular weight greater than 1500 are formulated as compatible components, and the weight ratio of each component is: : 1 part of puerarin, 2.5-6.5 parts of polyethylene glycol, 0.5-2.0 parts of poloxamer. 2、根据权利要地注1所述的葛根素滴丸制剂,其特征在于各组份的重量配比为:葛根素1份,聚乙二醇3~5份,泊洛沙姆0.5~1份。2. The puerarin dripping pill preparation described in Note 1 of the claim is characterized in that the weight ratio of each component is: 1 part of puerarin, 3 to 5 parts of polyethylene glycol, and 0.5 to 1 part of poloxamer. share. 3、一种如权利要求1所述的葛根素滴丸的制备方法,其特征在于具体步骤如下:3. A preparation method of puerarin dripping pills as claimed in claim 1, characterized in that the specific steps are as follows: (1)按各组份的重量配比,将聚乙二醇、泊洛沙姆置于水浴上加热,使之熔融,加入葛根素,搅拌均匀,加入药用无水乙醇,搅拌助溶,持续搅拌,挥发乙醇,90~100℃保温待用;(1) According to the weight proportion of each component, heat polyethylene glycol and poloxamer on a water bath to melt them, add puerarin, stir evenly, add medicinal absolute ethanol, stir to aid dissolution, Stir continuously, volatilize ethanol, keep warm at 90-100°C for later use; (2)预热DW-1型滴丸机,使贮液室恒温为药液温度,冷却剂大豆油预冷至10~12℃,以28~32滴/分的滴速滴制;(2) Preheat the DW-1 type dripping pill machine, keep the temperature of the liquid storage room at the temperature of the liquid medicine, pre-cool soybean oil as the coolant to 10-12°C, and drip at a dropping speed of 28-32 drops/min; (3)在阀门口收集滴丸,滤除冷却剂,并吸除表面油渍,晾干,即得成型滴丸。(3) Collect the dripping pills at the valve port, filter out the coolant, absorb the oil stains on the surface, and dry them to obtain the shaped dripping pills.
CN 02155198 2002-12-19 2002-12-19 Kakonein preparations and their production Pending CN1424041A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02155198 CN1424041A (en) 2002-12-19 2002-12-19 Kakonein preparations and their production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02155198 CN1424041A (en) 2002-12-19 2002-12-19 Kakonein preparations and their production

Publications (1)

Publication Number Publication Date
CN1424041A true CN1424041A (en) 2003-06-18

Family

ID=4752577

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02155198 Pending CN1424041A (en) 2002-12-19 2002-12-19 Kakonein preparations and their production

Country Status (1)

Country Link
CN (1) CN1424041A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100364533C (en) * 2005-04-19 2008-01-30 北京正大绿洲医药科技有限公司 Pyrolidone hydrochloride drip pill and its preparation method
CN100364537C (en) * 2005-03-28 2008-01-30 北京正大绿洲医药科技有限公司 Cepharanthine drip pill and its preparation method
CN100453072C (en) * 2005-01-28 2009-01-21 北京正大绿洲医药科技有限公司 Banlangen dripping pills and preparation method thereof
CN1615899B (en) * 2003-11-13 2010-05-05 中国人民解放军军事医学科学院毒物药物研究所 Puerarin oral preparation
CN101804045A (en) * 2010-04-09 2010-08-18 上海新康制药厂 Application of puerarin
CN101569614B (en) * 2009-06-08 2011-03-30 成都医学院 A kind of puerarin-coated slow-release dropping pill and preparation method thereof
CN104622828A (en) * 2015-01-07 2015-05-20 太原工业学院 Preparation method of puerarin sustained-release dropping pill

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1615899B (en) * 2003-11-13 2010-05-05 中国人民解放军军事医学科学院毒物药物研究所 Puerarin oral preparation
CN100453072C (en) * 2005-01-28 2009-01-21 北京正大绿洲医药科技有限公司 Banlangen dripping pills and preparation method thereof
CN100364537C (en) * 2005-03-28 2008-01-30 北京正大绿洲医药科技有限公司 Cepharanthine drip pill and its preparation method
CN100364533C (en) * 2005-04-19 2008-01-30 北京正大绿洲医药科技有限公司 Pyrolidone hydrochloride drip pill and its preparation method
CN101569614B (en) * 2009-06-08 2011-03-30 成都医学院 A kind of puerarin-coated slow-release dropping pill and preparation method thereof
CN101804045A (en) * 2010-04-09 2010-08-18 上海新康制药厂 Application of puerarin
CN104622828A (en) * 2015-01-07 2015-05-20 太原工业学院 Preparation method of puerarin sustained-release dropping pill
CN104622828B (en) * 2015-01-07 2017-10-13 太原工业学院 A kind of preparation method of puerarin sustained-release dropping pills

Similar Documents

Publication Publication Date Title
TWI254634B (en) Extrusion process for forming chemically stable drug multiparticulates
JP4213383B2 (en) Hydrophilic polymer thin film multilayer drug for rapid release of active ingredients
RU2428179C2 (en) Preparative forms of medications against dementia for transcutaneous introduction
KR100459747B1 (en) Rosesia Therapeutics
JP2022116191A (en) Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
CN1424041A (en) Kakonein preparations and their production
US7737130B2 (en) Pharmaceutical compositions for topical use in treatment of skin or mucous injuries
CN1202816C (en) Glimepiride dripping pills
CN112110889B (en) Scutellarin aglycone derivative, preparation method and application thereof
US20080145318A1 (en) Atomoxetine formulations and associated methods
WO2020190072A1 (en) Composition for promoting skin wound healing or skin regeneration, containing (r)-ginsenoside rg3 as active ingredient
CN102716135A (en) Application of lupenone to products for preventing or treating diabetes mellitus
KR960011240B1 (en) Drugs for the treatment of heart failure
CN109200273B (en) Application of polypeptide in preparation of medicine for preventing or treating fatty liver disease
CN102836211A (en) Salvia miltiorrhiza-lobed kudzuvine root eyesight improving in-situ gel
CN102525991A (en) Compound preparation containing pioglitazone hydrochloride and metformin hydrochloride and method for preparing compound preparation containing pioglitazone hydrochloride and metformin hydrochloride
CN101404981A (en) Methods and compositions for treatment of diastolic heart failure
CN105777712B (en) Tetrahydroisoquinoliderivs derivs and its application
CN100364533C (en) Pyrolidone hydrochloride drip pill and its preparation method
JPH0358923A (en) Treating diabetes mellitus
CN110327354B (en) Application of diosgenin in treatment and prevention of psoriasis
CN110496115B (en) Metformin ionic liquid and preparation and application thereof
CN1258364C (en) Formula of calebassine dripping pills and its preparation method
JP5164407B2 (en) Peripheral circulation improving drug
CN1449765A (en) Puerarin soft capsule pharmaceutics and preparation process thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication